Southeast Asset Advisors Inc. cut its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.8% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 48,726 shares of the medical instruments supplier’s stock after selling 880 shares during the quarter. DENTSPLY SIRONA makes up approximately 1.0% of Southeast Asset Advisors Inc.’s holdings, making the stock its 16th largest holding. Southeast Asset Advisors Inc.’s holdings in DENTSPLY SIRONA were worth $3,159,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in DENTSPLY SIRONA by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 22,728,062 shares of the medical instruments supplier’s stock worth $1,473,688,000 after buying an additional 562,993 shares during the last quarter. BlackRock Inc. increased its holdings in shares of DENTSPLY SIRONA by 3,103.7% in the 1st quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock valued at $867,376,000 after acquiring an additional 13,457,730 shares during the last quarter. State Street Corp increased its holdings in shares of DENTSPLY SIRONA by 0.4% in the 1st quarter. State Street Corp now owns 9,931,689 shares of the medical instruments supplier’s stock valued at $620,136,000 after acquiring an additional 36,012 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of DENTSPLY SIRONA by 22.3% in the 2nd quarter. Principal Financial Group Inc. now owns 6,474,432 shares of the medical instruments supplier’s stock valued at $419,802,000 after acquiring an additional 1,181,547 shares during the last quarter. Finally, Veritas Asset Management LLP increased its holdings in shares of DENTSPLY SIRONA by 2.6% in the 2nd quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock valued at $402,083,000 after acquiring an additional 157,616 shares during the last quarter. Institutional investors own 93.87% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was first posted by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was stolen and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this news story can be read at https://www.watchlistnews.com/southeast-asset-advisors-inc-has-3-16-million-holdings-in-dentsply-sirona-inc-xray/1608353.html.

DENTSPLY SIRONA Inc. (XRAY) traded up 2.07% on Wednesday, reaching $56.80. 1,932,275 shares of the company’s stock were exchanged. The firm has a 50-day moving average of $56.80 and a 200-day moving average of $61.33. DENTSPLY SIRONA Inc. has a 12 month low of $52.54 and a 12 month high of $65.68. The firm’s market capitalization is $13.04 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The business had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. During the same quarter last year, the company earned $0.76 EPS. DENTSPLY SIRONA’s revenue was down 2.9% on a year-over-year basis. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current year.

Several equities analysts recently issued reports on XRAY shares. HC Wainwright restated a “buy” rating and set a $68.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday. TheStreet lowered shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research note on Wednesday, August 9th. Morgan Stanley increased their target price on shares of DENTSPLY SIRONA from $66.00 to $67.00 and gave the stock an “overweight” rating in a report on Thursday, August 10th. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 target price on the stock in a report on Thursday, July 13th. Finally, BidaskClub downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Wednesday, July 19th. Three investment analysts have rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $65.80.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.